Lipocine - 53 Year Dividend History | LPCN
Historical dividend payout and yield for Lipocine (LPCN) since 1971. The current TTM dividend payout for Lipocine (LPCN) as of November 20, 2024 is $0.00. The current dividend yield for Lipocine as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.027B |
$0.001B |
|
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
